Inhibition of the Accumulation of Uremic Toxins in the Blood and Their Precursors in the Feces after Oral Administration of Lebenin®, a Lactic Acid Bacteria Preparation, to Uremic Patients Undergoing Hemodialysis

Cited by (297)

Items 101–200 of 297

  1. Involvement of voltage- and ligand-gated Ca2+ channels in the neuroexcitatory and synergistic effects of putative uremic neurotoxins
    Rudi D’Hooge, Gerda Van de Vijver, Pierre‐Paul van Bogaert, Bart Marescau, Raymond Camille Vanholder, Peter Paul De Deyn · 2003 · Kidney International
  2. Bisphenol A in Chronic Kidney Disease
    Emilio González‐Parra, José Antonio Herrero, Usama Elewa, Ricardo J. Bosch, Alberto Ortíz, Jesús Egido · 2013 · International Journal of Nephrology
  3. Gut Microbiome in Chronic Kidney Disease
    Rachel Gatti Armani, Ali Ramezani, A. Yasir, Shivani Sharama, Maria E. Canziani, Dominic S. Raj · 2017 · Current Hypertension Reports
  4. Gut Dysbiosis and the Intestinal Microbiome: Streptococcus thermophilus a Key Probiotic for Reducing Uremia
    Luis Vitetta, Hannah Llewellyn, Debbie Oldfield · 2019 · Microorganisms
  5. Removal of Protein‐Bound, Hydrophobic Uremic Toxins by a Combined Fractionated Plasma Separation and Adsorption Technique
    F. Brettschneider, Markus Tölle, Markus van der Giet et al. · 2013 · Artificial Organs
  6. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies
    Wei Dong Pan, Yongbo Kang · 2017 · International Urology and Nephrology
  7. Role and regulation of urea transporters
    Serena Maria Bagnasco · 2005 · Pflügers Archiv - European Journal of Physiology
  8. Modulation of Colon Cancer by Nutmeg
    Fei Li, Xiu-Wei Yang, Kristopher W. Krausz, Robert G. Nichols, Wei Xu, Andrew D. Patterson, Frank J. Gonzalez · 2015 · Journal of Proteome Research
  9. Gut microbiota dysbiosis in AKI to CKD transition
    Saranya Gunasekaran Rajalakshmi, Pragasam Viswanathan · 2023 · Biomedicine & Pharmacotherapy
  10. Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD
    Guus A. M. Kortman, Dorien Reijnders, Dorine W. Swinkels · 2017 · Hemodialysis International
  11. Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis
    Lee Daniel Chaves, Daniel Ian McSkimming, Mark A. Bryniarski, Amanda M. Honan, Sham Abyad, Shruthi A. Thomas, Steven Wells, Michael Joseph Buck, Yijun Sun, Robert J. Genco et al. · 2018 · American Journal of Physiology-Renal Physiology
  12. Effects of Prebiotic Fiber Xylooligosaccharide in Adenine‐Induced Nephropathy in Mice
    Jieping Yang, Qing Li, Susanne M. Henning, Jin Zhong, Mark Hsu, Ru‐Po Lee, Jianfeng Long, Brenda C. Chan, Glenn T. Nagami, David Heber et al. · 2018 · Molecular Nutrition & Food Research
  13. Superiority of 1-kestose, the Smallest Fructo-oligosaccharide, to a Synthetic Mixture of Fructo-oligosaccharides in the Selective Stimulating Activity on Bifidobacteria
    Nobuyuki Suzuki, Yuji Aiba, Hiroyuki Takeda · 2006 · Bioscience and Microflora
  14. Microbiome modulation as a novel therapeutic approach in chronic kidney disease
    Keiichi Sumida, Wei Ling Lau, Csaba Pal Kovesdy, Kamyar Kalantar‐Zadeh, Kourosh Kalantar‐Zadeh · 2020 · Current Opinion in Nephrology & Hypertension
  15. The human gut microbiome in health and disease: time for a new chapter?
    Jee‐Yon Lee, Derek J. Bays, Hannah P. Savage, Andreas J. Bäumler · 2024 · Infection and Immunity
  16. Decreasing microbiota-derived uremic toxins to improve CKD outcomes
    Braian M. Beker, Iara Colombo, Henry Joseth González-Torres, Carlos Guido Musso · 2022 · Clinical Kidney Journal
  17. Role of Gut-Derived Protein-Bound Uremic Toxins in Cardiorenal Syndrome and Potential Treatment Modalities
    Suree Lekawanvijit · 2015 · Circulation Journal
  18. Galacto-oligosaccharides attenuate renal injury with microbiota modification
    Satoshi Furuse, Takamoto Ohse, Airi Jo‐Watanabe, Akira Shigehisa, Koji Kawakami, Takahiro Matsuki, Osamu Chonan, Masaomi Nangaku · 2014 · Physiological Reports
  19. Protein-bound uremic toxins: a long overlooked culprit in cardiorenal syndrome
    Suree Lekawanvijit, Andrew R. Kompa, Henry Krum · 2016 · American Journal of Physiology-Renal Physiology
  20. Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients
    Chih‐Yu Yang, Der‐Cherng Tarng · 2018 · Nephrology
  21. Effect of probiotics on the intestinal microbiota of hemodialysis patients: a randomized trial
    Sixiu Liu, Hua Liu, Lei Chen, Shanshan Liang, Kehui Shi, Wang Meng, Jinhong Xue, Quan He, Hongli Jiang · 2020 · European Journal of Nutrition
  22. Effect of Lactobacillus Rhamnosus on serum uremic toxins (phenol and P-Cresol) in hemodialysis patients: A double blind randomized clinical trial
    Farzad Eidi, Fatemeh Poor -reza Gholi, Alireza Ostadrahimi · 2018 · Clinical Nutrition ESPEN
  23. Floating SERS substrates of silver nanoparticles-graphene based nanosheets for rapid detection of biomolecules and clinical uremic toxins
    Ruey‐Shin Juang, Kuan-Syun Wang, Yu‐Wei Cheng · 2019 · Colloids and Surfaces A Physicochemical and Engineering Aspects
  24. Protein-bound uremic retention solutes
    Philippe Brunet, Laetitia Dou, Claire Cérini · 2003 · Advances in Renal Replacement Therapy
  25. Exploring the Preventive and Therapeutic Mechanisms of Probiotics in Chronic Kidney Disease through the Gut–Kidney Axis
    Hsiao-Wen Huang, Ming‐Ju Chen · 2024 · Journal of Agricultural and Food Chemistry
  26. From the Gastrointestinal Tract (GIT) to the Kidneys: Live Bacterial Cultures (Probiotics) Mediating Reductions of Uremic Toxin Levels via Free Radical Signaling
    Luis Vitetta, Anthony W. Linnane, Glenda Carolyn Gobe · 2013 · Toxins
  27. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease
    Daniel Yuhang Li, W.H. Wilson Tang · 2018 · Seminars in Nephrology
  28. Gut microbiota dynamics and uraemic toxins: one size does not fit all
    Marie Joossens, Karoline Faust, Tessa Gryp, Anh Thi Nguyen, Jun Wang, Sunny Eloot, Eva Schepers, Annemieke Dhondt, Anneleen Pletinck, Sara Vieira‐Silva et al. · 2018 · Gut
  29. The effects of prebiotic, probiotic, and synbiotic supplementation on blood parameters of renal function: A systematic review and meta-analysis of clinical trials
    Somayyeh Firouzi, Fahimeh Haghighatdoost · 2018 · Nutrition
  30. Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism
    Phyllis P. Sun, Mary C. Perianayagam, Bertrand L. Jaber · 2009 · Kidney International
  31. Dietary nucleic acids promote a shift in Th1/Th2 balance toward Th1‐dominant immunity
    Nobuyuki Sudo, Aiba, Takaki, Tanaka, Yu, Oyama, Koga, Kubo · 2000 · Clinical & Experimental Allergy
  32. Regulated expression of renal and intestinal UT-B urea transporter in response to varying urea load
    Hideki Inoue, Shelley D. Kozlowski, Janet D. Klein, James Lynch Bailey, Jeff M. Sands, Serena Maria Bagnasco · 2005 · American Journal of Physiology-Renal Physiology
  33. Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components
    Mateo Ondrussek-Sekac, Diana Navas-Carrillo, Esteban Orenes‐Piñero · 2020 · Critical Reviews in Food Science and Nutrition
  34. Gut microbiota diversity in middle-aged and elderly patients with end-stage diabetic kidney disease
    Rongping Chen, Dan Zhu, Rui Yang, Zezhen Wu, Ningning Xu, Fengwu Chen, Shuo Zhang, Hong Chen, Ming Li, Kejun Hou · 2022 · Annals of Translational Medicine
  35. Prevention of nephrolithiasis by Lactobacillus in stone-forming rats: a preliminary study
    Cheol Hun Kwak, Byong Chang Jeong, Ja Hyeon Ku, Hyeon Hoe Kim, Jong Young Lee, Chul Sung Huh, Y.J. Baek, Sang Eun Lee · 2006 · Urological Research
  36. Binding of p-Cresylsulfate and p-Cresol to Human Serum Albumin Studied by Microcalorimetry
    David Bergé‐Lefranc, Florence Chaspoul, Raymond Calaf · 2010 · The Journal of Physical Chemistry B
  37. Targeting protein-bound uremic toxins in chronic kidney disease
    Toshimitsu Niwa · 2013 · Expert Opinion on Therapeutic Targets
  38. Use of Alternative Medicine by Patients With Stage 5 Chronic Kidney Disease
    Jerrilynn Denise Burrowes, Gloria Van Houten · 2005 · Advances in Chronic Kidney Disease
  39. The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies
    Zijing Tang, Shiyan Yu, Yu Pan · 2023 · Journal of Translational Medicine
  40. Controlling pepper soft rot by Lactobacillus paracasei WX322 and identification of multiple bacteriocins by complete genome sequencing
    Teng Qi, Shupei Wang, Lili Deng, Lanhua Yi, Kaifang Zeng · 2020 · Food Control
  41. The impact of dietary nutrient intake on gut microbiota in the progression and complications of chronic kidney disease
    Laetitia Koppe, Christophe Olivier Soulage · 2022 · Kidney International
  42. New Insights into Molecular Mechanisms of Chronic Kidney Disease
    Weronika Frąk, Joanna Kućmierz, Magdalena Szlagor, Ewelina Młynarska, Jacek Rysz, Beata Franczyk · 2022 · Biomedicines
  43. Contribution of ‘clinically negligible’ residual kidney function to clearance of uremic solutes
    Stephanie M. Toth‐Manikowski, Tammy Lisa Sirich, Timothy W. Meyer, Thomas H. Hostetter, Seungyoung Hwang, Natalie S. Plummer, Xin Hai, Josef Coresh, Neil R. Powe, Tariq Shafi · 2019 · Nephrology Dialysis Transplantation
  44. Effects of gluten-free, dairy-free diet on childhood nephrotic syndrome and gut microbiota
    Natalie Uy, Lauren Graf, Kevin V. Lemley, Frederick J. Kaskel · 2014 · Pediatric Research
  45. Changes in gut microbial community upon chronic kidney disease
    Wu Liu, Jiaqi Huang, Tong Liu, Yutian Hu, Kaifeng Shi, Yi Zhou, Ning Zhang · 2023 · PLoS ONE
  46. Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection
    Sun Chul Kim, Min Young Seo, Jun Yong Lee · 2015 · The Korean Journal of Internal Medicine
  47. Cytotoxic Effects of p-Cresol in Renal Epithelial Tubular Cells
    Alessandra Brocca, Grazia Maria Virzì, Massimo de Cal · 2013 · Blood Purification
  48. Purple Urine Bag Syndrome in a Hemodialysis Patient
    I‐Kuan Wang, Dong‐Ru Ho, Hung‐Yu Chang · 2005 · Internal Medicine
  49. Free and MicroencapsulatedLactobacillusand Effects of Metabolic Induction on Urea Removal
    Kai Ming Chow, Zun Chang Liu, Satya Prakash · 2003 · Artificial Cells Blood Substitutes and Biotechnology
  50. The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions
    Hanan Qasem, Wael Mohamed El-Sayed · 2024 · Clinical and Experimental Medicine
  51. The uremic solute p-cresol decreases leukocyte transendothelial migration in vitro
    Valérie Faure · 2006 · International Immunology
  52. Peritoneal Microbiome in End-Stage Renal Disease Patients and the Impact of Peritoneal Dialysis Therapy
    Liliana Simões‐Silva, Ricardo Araújo, Manuel Pestana, Isabel Soares‐Silva, Benedita Sampaio‐Maia · 2020 · Microorganisms
  53. Gases as Uremic Toxins: Is There Something in the Air?
    Joachim Jankowski, Timm Westhof, Nosratola D. Vaziri, Diego Ingrosso, Alessandra Fortunata Perna · 2014 · Seminars in Nephrology
  54. Nonextracorporeal Methods for Decreasing Uremic Solute Concentration: A Future Way To Go?
    Björn K.I. Meijers, Griet Glorieux, Ruben Poesen, Stephan J. L. Bakker · 2014 · Seminars in Nephrology
  55. A synbiotic supplement for inflammation and oxidative stress and lipid abnormalities in hemodialysis patients
    Akram Kooshki, Tahereh Tofighiyan, Mohammad Miri · 2019 · Hemodialysis International
  56. Alleviating chronic kidney disease progression through modulating the critical genus of gut microbiota in a cisplatin-induced Lanyu pig model
    Ya‐Jane Lee, Kuanyi Li, Pin-Jhu Wang, Hsiao‐Wen Huang, Ming‐Ju Chen · 2019 · Journal of Food and Drug Analysis
  57. Gut Microbiota-Targeted Interventions in the Management of Chronic Kidney Disease
    Keiichi Sumida, Joseph F. Pierre, melana yuzefpolskaya, P.C. Colombo, Ryan T. Demmer, Csaba Pal Kovesdy · 2023 · Seminars in Nephrology
  58. Gut Microbiome Profiling Uncovers a Lower Abundance of Butyricicoccus in Advanced Stages of Chronic Kidney Disease
    Tessa Gryp, Karoline Faust, Wim Van Biesen, Geert R. B. Huys, Francis Verbeke, Marijn M. Speeckaert, Jeroen Raes, Mario Vaneechoutte, Marie Joossens, Griet Glorieux · 2021 · Journal of Personalized Medicine
  59. Intestinal bacteria-derived putrefactants in chronic renal failure
    Fumiko Fukuuchi, M. Hida, Y. Aiba · 2002 · Clinical and Experimental Nephrology
  60. Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population
    Marika Mikelsaar, Epp Sepp, Jelena Štšepetova, Epp Songisepp, Reet Mändar · 2016 · Advances in experimental medicine and biology
  61. The role of chronic kidney disease-associated dysbiosis in cardiovascular disease
    Mark A. Bryniarski, Fares Hamarneh, Rabi Yacoub · 2019 · Experimental Biology and Medicine
  62. The cross-talk between the kidney and the gut: implications for chronic kidney disease
    Laila Santos de Andrade, Christiane Ishikawa Ramos, Lílian Cuppari · 2017 · Nutrire
  63. A Bifunctional Adsorber Particle for the Removal of Hydrophobic Uremic Toxins from Whole Blood of Renal Failure Patients
    Marieke Sternkopf, Sven Thoröe‐Boveleth, Tobias Beck et al. · 2019 · Toxins
  64. Strongyloides stercoralis infection induces gut dysbiosis in chronic kidney disease patients
    Nguyen Thi Hai, Nuttanan Hongsrichan, Kitti Intuyod, Porntip Pinlaor, Manachai Yingklang, Apisit Chaidee, Thatsanapong Pongking, Sirirat Anutrakulchai, Ubon Cha’on, Somchai Pinlaor · 2022 · PLoS neglected tropical diseases
  65. Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy
    Griet Glorieux, James E. Tattersall · 2015 · Clinical Kidney Journal
  66. Effects of synbiotic supplementation on microbiota-derived protein-bound uremic toxins, systemic inflammation, and biochemical parameters in patients on hemodialysis: A double-blind, placebo-controlled, randomized clinical trial
    Soheila Mirzaeian, Sahar Saraf‐Bank, Mohammad Hassan Entezari · 2019 · Nutrition
  67. On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease
    Cem Tanrıöver, Duygu Uçku, Carlo Basile, Katherine R. Tuttle, Mehmet Kanbay · 2022 · Journal of Nephrology
  68. Lactobacillus acidophilus KBL409 Reduces Kidney Fibrosis via Immune Modulatory Effects in Mice with Chronic Kidney Disease
    Hyoungnae Kim, Bo Young Nam, Jimin Park, Seokcheon Song, Woon-Ki Kim, Kiuk Lee, Tae-Wook Nam, Jung Tak Park, Tae‐Hyun Yoo, Shin‐Wook Kang et al. · 2022 · Molecular Nutrition & Food Research
  69. Gut Microbiota Interventions to Retain Residual Kidney Function
    Denise Mafra, Julie Ann Kemp, Natália Alvarenga Borges, Michelle Wong, Peter Stenvinkel · 2023 · Toxins
  70. Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update
    Alessandro Di Cerbo, Federica Pezzuto, Lucia Palmieri, Valentina Rottigni, Tommaso Iannitti, Beniamino Palmieri · 2013 · International Urology and Nephrology
  71. Dietary Galacto-Oligosaccharides Mixture Can Suppress Serum Phenol and p-Cresol Levels in Rats Fed Tyrosine Diet
    Koji Kawakami, I Marinò, Takashi Asahara · 2005 · Journal of Nutritional Science and Vitaminology
  72. Gut flora-based therapy in liver disease? The liver cares about the gut
    Steven F. Solga, Anna Mae Diehl · 2004 · Hepatology
  73. The influence of gut microbiota on the gut-brain-kidney axis and its implications for chronic kidney disease
    Jue Zhu, Yutong Fu, Chinasa Valerie Olovo, Jianguo Xu, Qian Wu, Wei Wei, Ke Jiang, Xueming Zheng · 2025 · Frontiers in Microbiology
  74. p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis
    Hye Sun Hyun, Kyung Hoon Paik, Hee Yeon Cho · 2013 · Korean Journal of Pediatrics
  75. Oral administration of Bifidobacterium longum in a gastro-resistant seamless capsule decreases serum phosphate levels in patients receiving haemodialysis
    T. Ogawa, Makoto K. Shimada, Nobuo Nagano · 2012 · Clinical Kidney Journal
  76. Redesigning the Map of Uremic Toxins
    R. Vanholder, Rebecca De Smet, Norbert Hendrik Lameire · 2001 · KARGER eBooks
  77. Does the Composition of Gut Microbiota Affect Chronic Kidney Disease? Molecular Mechanisms Contributed to Decreasing Glomerular Filtration Rate
    Ewelina Młynarska, Emilian Budny, Maciej Saar, Ewa Wojtanowska, Justyna Jankowska, Szymon Marciszuk, Marcin Mazur, Jacek Rysz, Beata Franczyk · 2024 · International Journal of Molecular Sciences
  78. Derivation and elimination of uremic toxins from kidney-gut axis
    Ying Xu, Wen-Di Bi, Yu-Xuan Shi, Xin-Rui Liang, Hai-Yan Wang, Xueli Lai, Xiaolu Bian, Zhiyong Guo · 2023 · Frontiers in Physiology
  79. The Relationship between Serum Oxalic Acid, Central Hemodynamic Parameters and Colonization by Oxalobacter formigenes in Hemodialysis Patients
    Barış Gülhan, Kültiğin Türkmen, Merve Aydın, Murat Günay, Aytekin Çıkman, Murat Kara · 2015 · Cardiorenal Medicine
  80. Therapeutic potential of different commercially available synbiotic on acetaminophen-induced uremic rats
    Arpita Mandal, Arpita Patra, Shreya Mandal, Suchismita Roy, Shreya Das Mahapatra, Tapasi Das Mahapatra, Tanmay Paul, Koushik Das, Keshab Chandra Mondal, Dilip Kumar Nandi · 2014 · Clinical and Experimental Nephrology
  81. Therapeutic Prospective of a Spore-Forming Probiotic—Bacillus clausii UBBC07 Against Acetaminophen-Induced Uremia in Rats
    Chirag Amrutlal Patel, Priyanshi R. Patel, Sanjeev R. Acharya · 2019 · Probiotics and Antimicrobial Proteins
  82. Assessment of uremic toxins in advanced chronic kidney disease patients on maintenance hemodialysis by LC-ESI-MS/MS
    Nagarjunachary Ragi, Pavankumar Pallerla, Aravind Reddy Babi Reddy Gari · 2023 · Metabolomics
  83. Protein-bound toxins: has the Cinderella of uraemic toxins turned into a princess?
    Sophie Liabeuf, Cédric Villain, Ziad A. Massy · 2016 · Clinical Science
  84. Preventive effects of Lactobacillus johnsonii on the renal injury of mice induced by high fluoride exposure: insights from colonic microbiota and co-occurrence network analysis
    Xin, Jinge, Sun, Ning, Wang, Hesong, Ma, Hailin, Wu, Bangyuan, Li, Lianxin, Wang, Yanyan, Huang, Haonan, Zeng, Dong, Bai, Xiuquan et al. · 2021 · Ecotoxicology and Environmental Safety
  85. Use of probiotics in patients with chronic kidney disease on hemodialysis: a randomized clinical trial
    Érica Maria Rodrigues de Araújo, Gdayllon Cavalcante Meneses, Antônio Augusto Ferreira Carioca, Alice Maria Costa Martins, Elizabeth De Francesco Daher, Geraldo Bezerra da Silva · 2022 · Brazilian Journal of Nephrology
  86. In vivo assessment of bacteriotherapy on acetaminophen-induced uremic rats
    Arpita Mandal, Koushik Das, Suchismita Roy, Keshab Chandra Mondal, Dilip Kumar Nandi · 2012 · Journal of Nephrology
  87. Protection of Residual Renal Function and Nutritional Treatment: First Step Strategy for Reduction of Uremic Toxins in End-Stage Kidney Disease Patients
    Adamasco Cupisti, Piergiorgio Bolasco, Claudia D’Alessandro, Domenico Giannese, Alice Sabatino, Enrico Fiaccadori · 2021 · Toxins
  88. Selection of uremic toxin-reducing probiotics in vitro and in vivo
    Chen-Yu Fang, Je-Ruei Lu, Bao‐Ji Chen, Chieh Hsi Wu, Yen‐Po Chen, Ming‐Ju Chen · 2014 · Journal of Functional Foods
  89. The Role of Gut-Derived, Protein-Bound Uremic Toxins in the Cardiovascular Complications of Acute Kidney Injury
    Pauline Caillard, Youssef Bennis, Isabelle Six, Sandra Bodeau, Saı̈d Kamel, Gabriel J. Choukroun, Julien Maizel, Dimitri Titeca Beauport · 2022 · Toxins
  90. Inflammation in Chronic Kidney Disease
    Dominic S. Raj, Roberto Pecoits‐Filho, Paul L. Kimmel · 2014 · Elsevier eBooks
  91. Experimental and numerical modeling of dialysis
    Sunny Eloot · 2004 · Ghent University Academic Bibliography (Ghent University)
  92. Unconjugated p-cresol activates macrophage macropinocytosis leading to increased LDL uptake
    Lee Daniel Chaves, Sham Abyad, Amanda M. Honan, Mark A. Bryniarski, Daniel Ian McSkimming, Corrine M. Stahura, Steven C. Wells, Donna M. Ruszaj, Marilyn E. Morris, Richard John Quigg et al. · 2021 · JCI Insight
  93. Interaction of Human Serum Albumin with Uremic Toxins: The Need of New Strategies Aiming at Uremic Toxins Removal
    Fahimeh Zare, Adriana Janeca, Seyyed Mohammad Jokar · 2022 · Membranes
  94. Could Physical Exercise Help Modulate the Gut Microbiota in Chronic Kidney Disease?
    Marta Esgalhado, Natália Alvarenga Borges, Denise Mafra · 2016 · Future Microbiology
  95. Ordered porous materials for blood purification
    Minjun Zhang, Xinjie Liu, Wan Zhou, Xiaolong Zheng, Shenqi Wang, Lei Zhou · 2023 · Separation and Purification Technology
  96. The relationship between colonization of Oxalobacter formigenes serum oxalic acid and endothelial dysfunction in hemodialysis patients: From impaired colon to impaired endothelium
    Kültiğin Türkmen, Fatih Mehmet Erdur · 2015 · Medical Hypotheses
  97. Serum Concentration of p-Cresol and Indoxyl Sulfate in Elderly Hemodialysis Patients
    Cheng‐Jui Lin, Chih‐Jen Wu, Chi‐Feng Pan · 2011 · International journal of gerontology
  98. Indoxyl sulphate and p-cresyl sulphate: therapeutically modifiable nephrovascular toxins
    Megan Rossi, K N Campbell, David Wayne Johnson · 2013 · OA Nephrology
  99. Effects of uremic ultrafiltrate on the regulation of the parathyroid cell cycle by calcitriol
    Antonio Canalejo, Yolanda Almadén, Rita De Smet · 2003 · Kidney International
  100. The Effect of Synbiotic Supplementation on Uremic Toxins, Oxidative Stress, and Inflammation in Hemodialysis Patients—Results of an Uncontrolled Prospective Single-Arm Study
    Teodor Kuskunov, Eduard E. Tilkiyan, Daniel Ilianov Doykov, Krasimir Boyanov, Anelia Veselinova Bivolarska, Bozhidar Krasimirov Hristov · 2023 · Medicina